FDA panel: Avandia should stay on market - Fox29 WFLX TV, West Palm Beach, FL-news & weather

FDA panel: Avandia should stay on market

WASHINGTON (AP) - A majority of federal health experts has voted to keep diabetes pill Avandia on the market. That's despite evidence that it increases the risk of heart attack.

A panel of FDA voted against withdrawing GlaxoSmithKline's once-blockbuster drug. Panelists who voted to keep the drug on the market were split between several options, including adding new warning labels and restricting use of the drug.

The vote marks a win for British drugmaker Glaxo, which has been battered in the press and on Capitol Hill for its the handling of the drug.

The FDA is not required to follow the advice of its panelists, though it usually does. Officials said they would review the meeting transcript and make a decision on Avandia as soon as possible.

Powered by Frankly

1100 Banyan Blvd.
West Palm Beach, FL 33401

FCC Public File
EEO Report
Closed Captioning

All content © Copyright 2000 - 2018 Raycom Media. All Rights Reserved.
For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.